Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)

Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)

IntroductionMultiple Sclerosis (MS) is the most common neuroimmunological disease in women of childbearing age. Current MS therapy consists of immunomodulatory relapse prevention with disease-modifying therapies (DMTs) and acute relapse therapy with the synthetic glucocorticoid (GC) methylprednisolo...

Full description

Bibliographic Details
Main Authors:	Valeska Kozik, Matthias Schwab, Sandra Thiel, Kerstin Hellwig, Florian Rakers, Michelle Dreiling
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Neurology
Subjects:	Multiple sclerosis glucocorticoids methylprednisolone cognition pituitary-adrenal axis
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.830057/full

Similar Items

Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)
by: Frontiers Production Office
Published: (2023-05-01)

Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate
by: Katarzyna Pelewicz, et al.
Published: (2020-10-01)

Stress, Allostatic Load, and Psychosis: One Step Forward in Research But Where to Go Next?
by: Błażej Misiak
Published: (2020-01-01)

Perinatal programming of neuroendocrine mechanisms connecting feeding behavior and stress
by: Sarah J Spencer
Published: (2013-06-01)

The Association between Maternal Stress and Glucocorticoid Rhythmicity in Human Milk
by: Michelle Romijn, et al.
Published: (2021-05-01)

Síndrome de deprivación glucocorticoidea. A propósito de un caso
by: Arnella Torres Álvarez, et al.

Circadian glucocorticoids throughout development
by: Marianne Lehmann, et al.
Published: (2023-04-01)

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel
by: Mojca Jensterle, et al.
Published: (2022-06-01)

Platelet Levels of High- and Mega-Dose Methylprednisolone Treatment in Acute Immune Thrombocytopenia
by: Ali Ayçiçek
Published: (2015-05-01)

Efficacy and safety of a 30-day methylprednisolone treatment protocol for subacute thyroiditis: a prospective study
by: Katica Bajuk Studen, et al.
Published: (2023-10-01)

Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
by: Jody A. Rusch, et al.
Published: (2023-06-01)

Optimising prednisolone or prednisone replacement in adrenal insufficiency
by: Angelica Sharma, et al.
Published: (2023-07-01)

Evaluation of maternal cortisol-to-highly sensitive C-reactive protein ratio and glucocorticoid receptor resistance at 11–14 weeks of pregnancy to predict pre-eclampsia
by: K Jhansi, et al.
Published: (2022-01-01)

Understanding the relationships between physiological and psychosocial stress, cortisol and cognition
by: Katharine Ann James, et al.
Published: (2023-03-01)

Response of the nitrergic system to activation of the neuroendocrine stress axis
by: Hsiao-Jou Cortina eChen, et al.
Published: (2015-01-01)

The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
by: Sirazum Choudhury, et al.
Published: (2021-03-01)

A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
by: Shukun Hong, et al.
Published: (2023-05-01)

Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone
by: Montserrat Gonzalez-Platas, et al.
Published: (2018-10-01)

Hypothalamic–pituitary–adrenal axis activation and glucocorticoid‐responsive gene expression in skeletal muscle and liver of Apc mice
by: Agnès Martin, et al.
Published: (2022-06-01)

Corticotropin-Releasing Hormone As the Homeostatic Rheostat of Feto-Maternal Symbiosis and Developmental Programming In Utero and Neonatal Life
by: Viridiana Alcántara-Alonso, et al.
Published: (2017-07-01)

Antidepressant-like mechanism of honokiol in a rodent model of corticosterone-induced depression
by: Bo Zhang, Yu Li, Miao Liu, Xiao-Hua Duan, Kai-Li Hu, Li-Na Li, Xue Yu, Hong-Sheng Chang
Published: (2020-09-01)

The Peacock study: feasibility of the dynamic characterisation of the paediatric hypothalamic-pituitary-adrenal function during and after cardiac surgery
by: Daniel Paul Fudulu, et al.
Published: (2020-05-01)

Paraventricular Hypothalamic Mechanisms of Chronic Stress Adaptation
by: James P Herman, et al.
Published: (2016-10-01)

The behavioral and neurochemical effects of methylprednisolone or metyrapone in a post-traumatic stress disorder rat model
by: Ayşe Melek Tanriverdi Bademci, et al.
Published: (2019-11-01)

The ACTH axis : pathogenesis, diagnosis, and treatment /
by: Gaillard, Rolf C.
Published: (2003)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01)

Nutraceutical Interventions for Post-Traumatic Stress Disorder in Animal Models: A Focus on the Hypothalamic–Pituitary–Adrenal Axis
by: Mudan Cai, et al.
Published: (2022-07-01)

Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription
by: Dongyun Zhang, et al.
Published: (2020-04-01)

Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
by: Tomasz P. Lehmann, et al.
Published: (2023-01-01)

Copeptin Levels in Clinically Silent Multiple Sclerosis
by: İrem İlgezdi, et al.
Published: (2022-12-01)

Glucocorticoid Negative Feedback in Regulation of the Hypothalamic-Pituitary-Adrenal Axis in Rhesus Monkeys With Various Types of Adaptive Behavior: Individual and Age-Related Differences
by: Nadezhda Goncharova, et al.
Published: (2019-02-01)

A naturally hypersensitive glucocorticoid receptor elicits a compensatory reduction of hypothalamus–pituitary–adrenal axis activity early in ontogeny
by: Eduard Muráni, et al.
Published: (2016-01-01)

Circulating IL-6 and neopterin concentrations link cell-mediated immunity and tumor stage in patients with gastro-intestinal adenocarcinoma: relevance to the pituitary-adrenal axis and pituitary-thyroid axis
by: Engin Ayse Basak, et al.
Published: (2016-06-01)

Insulinoma-associated Transient Hypothalamus—Pituitary—Adrenal Axis Impairment and Amelioration by Steroid Therapy and Surgical Intervention: A Case Report
by: Yu-Hung Chang, et al.
Published: (2007-10-01)

Is PTSD-Phenotype Associated with HPA-Axis Sensitivity? Feedback Inhibition and Other Modulating Factors of Glucocorticoid Signaling Dynamics
by: Dor Danan, et al.
Published: (2021-06-01)

Epigenomic mechanisms of early adversity and HPA dysfunction: Considerations for PTSD research
by: Patrick O McGowan
Published: (2013-09-01)

Eating behaviour and stress: a pathway to obesity
by: Sarah J Spencer, et al.
Published: (2014-05-01)

Treatment of Methylprednisolone Allergy with Dexamethasone
by: Öner Özdemir, et al.
Published: (2017-06-01)

Challenges and solutions to recruitment of neonates and children having cardiac surgery into a study using a novel sampling device
by: Terrie Walker-Smith, et al.
Published: (2022-06-01)

Adrenal Gland Irradiation Causes Fatigue Accompanied by Reactive Changes in Cortisol Levels
by: Yu-Ming Huang, et al.
Published: (2022-02-01)